Taliaz Health develops predictive tools based on genetic, clinical, and demographic data to determine the most appropriate treatment for each patient. The company provides a decision-support tool for personalized treatment using in-house big data and machine-learning algorithms that were developed to predict responses to medication. The software tool uses a simple, noninvasive test to find a drug with the least adverse effects that will best suit the patient.The company’s first product determines the right antidepressant medication for individuals suffering from depression. The company also develops algorithms for other neuropsychiatric conditions including schizophrenia, attention deficit hyperactivity disorder, anxiety disorders, and bipolar affective disorder.